HNF4alpha Dysfunction as a Molecular Rational for Cyclosporine Induced Hypertension
2011

HNF4alpha Dysfunction and Cyclosporine Induced Hypertension

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): Monika Niehof, Jürgen Borlak

Primary Institution: Center of Molecular Medicine and Medical Biotechnology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany

Hypothesis

The study investigates the effect of cyclosporine on HNF4alpha expression and its role in hypertension.

Conclusion

Cyclosporine represses HNF4alpha activity, leading to a disturbed balance of the renin-angiotensin system and resulting in hypertension.

Supporting Evidence

  • Cyclosporine treatment significantly reduced the expression of HNF4alpha and its target genes.
  • The study identified angiotensin II receptor type 1, ACE, and ACE2 as genes targeted by HNF4alpha.
  • HNF4alpha DNA-binding activity was inhibited by cyclosporine, affecting gene expression in the renin-angiotensin system.

Takeaway

Cyclosporine, a drug used to prevent organ rejection, can cause high blood pressure by affecting a protein called HNF4alpha, which helps control blood pressure.

Methodology

The study used human hepatoma cells treated with cyclosporine to analyze gene expression and protein activity related to the renin-angiotensin system.

Statistical Information

P-Value

0.0014

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016319

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication